You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. (D. Del. 2018)

✉ Email this page to a colleague

« Back to Dashboard

Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. (D. Del. 2018)

Docket	⤷ Sign Up	Date Filed	2018-10-26
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	None	Referred To	Sherry R. Fallon
Parties	MSN PHARMACEUTICALS INC.
Patents	10,258,637; 7,579,449; 7,713,938; 8,551,957; 9,949,997; 9,949,998
Attorneys	Michael K. Nutter
Firms	KL Gates LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. (D. Del. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2019-09-27	113	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,449 B2 ;7,713,938 B2 ;8,551,957… 26 October 2018 1:18-cv-01689 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-10-11	123	Stipulation-General (See Motion List for Stipulation to Extend Time)	STIPULATION of Dismissal Regarding U.S. Pat. No. 9,949,997 as to Defendants Annora Pharma Private Ltd. and… 26 October 2018 1:18-cv-01689 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-10-16	126	SO ORDERED	Stipulation of Dismissal Regarding U.S. Pat. No. 9,949,997 as to Defendants Annora Pharma Private Ltd. and… 26 October 2018 1:18-cv-01689 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-10-30	132	Claim Construction Chart	identified claim terms of U.S. Patents Nos. 8,551,957 and 7,713,938. Agreed-upon constructions are… U.S. Patent No. 7,713,938 Claim(s) Term/Phrase …Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1 - '938 Patent, # 2 Exhibit 2 - '938 Notice of Allowance)(Dellinger… U.S Patent No. 8,551,957 Claim(s) Term/Phrase … 26 October 2018 1:18-cv-01689 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2020-04-10	240	Stipulation of Dismissal	SEALED] STIPULATION of Dismissal of U.S. Patent No. 7,713,938 by Alkem Laboratories Ltd.. (Ormerod, Eve… 26 October 2018 1:18-cv-01689 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.